# Molecular Breast Imaging: A Novel Technology for Detection of Malignant Breast Lesions

> **NCT01004666** · — · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 500 (estimated)

## Conditions studied

- Small Breast Lesions
- Dense Breast Tissue
- Discrepancy With Clinical Examination
- Equivocal Mammographic, Sonographic or MRI Lesion

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01004666
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-10
- **Primary completion:** 2014-10
- **Final completion:** 2015-10
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2013-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01004666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01004666, "Molecular Breast Imaging: A Novel Technology for Detection of Malignant Breast Lesions". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01004666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*